Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020182106 - MIRNA MARKERS FOR COLORECTAL CANCER

Publication Number WO/2020/182106
Publication Date 17.09.2020
International Application No. PCT/CN2020/078497
International Filing Date 10.03.2020
IPC
C12Q 1/6886 2018.01
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
1Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
68involving nucleic acids
6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
6883for diseases caused by alterations of genetic material
6886for cancer
C12N 15/11 2006.01
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
15Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
09Recombinant DNA-technology
11DNA or RNA fragments; Modified forms thereof
Applicants
  • THE CHINESE UNIVERSITY OF HONG KONG [CN]/[CN]
Inventors
  • YU, Jun
  • SUNG, Jao Yiu
  • LIANG, Qiaoyi
Agents
  • INSIGHT INTELLECTUAL PROPERTY LIMITED
Priority Data
62/816,72411.03.2019US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) MIRNA MARKERS FOR COLORECTAL CANCER
(FR) MARQUEURS DE MIARN POUR LE CANCER COLORECTAL
Abstract
(EN)
The present invention provides novel methods for diagnosing colorectal cancer in a subject or for assessing a colorectal cancer patient's likelihood of mortality from the disease by analyzing the quantity of selected miRNA species. Kits, compositions, and devices useful for these methods are also provided.
(FR)
La présente invention concerne de nouveaux procédés pour diagnostiquer un cancer colorectal chez un sujet ou pour évaluer une probabilité de mortalité d'un patient atteint d'un cancer colorectal à partir de la maladie par analyse de la quantité d'espèces de miARN sélectionnées. L'invention concerne en outre des trousses et compositions associées à ces procédés.
Latest bibliographic data on file with the International Bureau